Clinical trial
Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in…
NCT00481533 · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Other · Completed
Key facts
| NCT number | NCT00481533 |
|---|---|
| Title | Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour |
| Official title | Prophylactic Ergonovine-Oxytocin Versus Oxytocin During Cesarean Delivery Following Failure to Progress in Labour |
| Lead sponsor | Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Blood Loss, Surgical |
| Intervention type | Drug |
| Interventions | Methyl-Ergonovine-Oxytocin, Oxytocin |
| Enrollment | 47 |
| Start date | Jun 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Jun 1, 2007 |
| Last update posted | Jun 1, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: